Bionabu

The submission for Bionabu contains severe inaccuracies and vague claims that contradict verifyable reality. While external research confirms Bionabu is a legitimate early-stage MedTech platform (pivoting to pediatric AI engagement) with around 1,000 users, the submission claims 'everyone' is the audience and 'most people' have used the product, which are objectively false. The 'marketcap' revenue figure appears to be a token valuation or unverified estimate rather than operating revenue. The discrepancy between the project name 'Bionabu' and the name 'SwiftHunter' in the input suggests a careless entry. The low score reflects the extremely poor quality of evidence provided, despite the underlying business having some genuine utility.